Catalys Pacific
Overview
An independent venture capital firm founded in 2019 that focuses on early-stage investments in life sciences, including biotherapeutics, MedTech, and diagnostics. The firm aims to bridge the innovation ecosystems of Japan and the United States, creating and investing in biotech companies.
Portfolio Companies
8
Website
catalyspacific.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mineralys Therapeutics | Feb 2023 | IPO | Co-investor |
| Pathalys Pharma | Aug 2024 | Series B | Co-investor |
| Crystalys Therapeutics | Jul 2026 | Series B | Co-investor |
| Kirilys Therapeutics | Mar 2022 | Seed | Co-investor |
| Arialys Therapeutics | Sep 2023 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Mitsuyuki MATSUMOTO
Operating Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Catalys Pacific based?
Catalys Pacific is headquartered in Tokyo, Tokyo, Japan.
When was Catalys Pacific founded?
Founding year information for Catalys Pacific is not publicly available.
How many portfolio companies does Catalys Pacific have?
Catalys Pacific has 8 portfolio companies in Caplight's dataset.
What are some companies in Catalys Pacific's portfolio?
Portfolio companies visible on Caplight include Mineralys Therapeutics, Pathalys Pharma, Crystalys Therapeutics, Kirilys Therapeutics, Arialys Therapeutics.
What was Catalys Pacific's most recent investment shown here?
Catalys Pacific's most recent investment in this portfolio sample was in Crystalys Therapeutics in 2026.
What sectors does Catalys Pacific focus on?
Catalys Pacific focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Catalys Pacific focus on?
Catalys Pacific typically invests at the Early stage.